J K Schultz1, N Azhar2,3, G A Binda4, G Barbara5, S Biondo6, M A Boermeester7, A Chabok8, E C J Consten9,10, S T van Dijk7, A Johanssen1, W Kruis11, D Lambrichts12, S Post13, F Ris14, T A Rockall15, A Samuelsson16,17, S Di Saverio18,19, D Tartaglia20, A Thorisson21,22, D C Winter23, W Bemelman7, E Angenete17,24. 1. Department of Gastrointestinal Surgery, Akershus University Hospital, Lørenskog, Norway. 2. Colorectal Unit, Department of Surgery, Skåne University Hospital Malmö, Malmö, Sweden. 3. Department of Clinical Sciences, Lund University, Malmö, Sweden. 4. Colorectal Surgery, BioMedical Institute, Genova, Italy. 5. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. 6. Department of General and Digestive Surgery - Colorectal Unit, Bellvitge University Hospital, University of Barcelona and IDIBELL, Barcelona, Spain. 7. Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands. 8. Colorectal Unit, Department of Surgery, Centre for Clinical Research Uppsala University, Västmanlands Hospital Västerås, Västerås, Sweden. 9. Department of Surgery, Meander Medical Centre, Amersfoort, The Netherlands. 10. Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands. 11. Faculty of Medicine, University of Cologne, Cologne, Germany. 12. Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. 13. Mannheim Faculty of Medicine, University of Heidelberg, Mannheim, Germany. 14. Division of Visceral Surgery, Geneva University hospitals and Medical School, Geneva, Switzerland. 15. Minimal Access Therapy Training Unit (mattu), Royal Surrey County Hospital NHS Trust, Guildford, UK. 16. Department of Surgery, NU-Hospital Group, Region Västra Götaland, Trollhättan, Sweden. 17. Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 18. Cambridge Colorectal Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. 19. Department of General Surgery, ASST Sette Laghi, University Hospital of Varese, University of Insubria, Varese, Italy. 20. Emergency Surgery Unit, New Santa Chiara Hospital, University of Pisa, Pisa, Italy. 21. Department of Radiology, Västmanland's Hospital Västerås, Västerås, Sweden. 22. Centre for Clinical Research of Uppsala University, Västmanland's Hospital Västerås, Västerås, Sweden. 23. St Vincent's University Hospital, Dublin, Ireland. 24. Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Abstract
AIM: The goal of this European Society of Coloproctology (ESCP) guideline project is to give an overview of the existing evidence on the management of diverticular disease, primarily as a guidance to surgeons. METHODS: The guideline was developed during several working phases including three voting rounds and one consensus meeting. The two project leads (JKS and EA) appointed by the ESCP guideline committee together with one member of the guideline committee (WB) agreed on the methodology, decided on six themes for working groups (WGs) and drafted a list of research questions. Senior WG members, mostly colorectal surgeons within the ESCP, were invited based on publication records and geographical aspects. Other specialties were included in the WGs where relevant. In addition, one trainee or PhD fellow was invited in each WG. All six WGs revised the research questions if necessary, did a literature search, created evidence tables where feasible, and drafted supporting text to each research question and statement. The text and statement proposals from each WG were arranged as one document by the first and last authors before online voting by all authors in two rounds. For the second voting ESCP national representatives were also invited. More than 90% agreement was considered a consensus. The final phrasing of the statements with < 90% agreement was discussed in a consensus meeting at the ESCP annual meeting in Vienna in September 2019. Thereafter, the first and the last author drafted the final text of the guideline and circulated it for final approval and for a third and final online voting of rephrased statements. RESULTS: This guideline contains 38 evidence based consensus statements on the management of diverticular disease. CONCLUSION: This international, multidisciplinary guideline provides an up to date summary of the current knowledge of the management of diverticular disease as a guidance for clinicians and patients.
AIM: The goal of this European Society of Coloproctology (ESCP) guideline project is to give an overview of the existing evidence on the management of diverticular disease, primarily as a guidance to surgeons. METHODS: The guideline was developed during several working phases including three voting rounds and one consensus meeting. The two project leads (JKS and EA) appointed by the ESCP guideline committee together with one member of the guideline committee (WB) agreed on the methodology, decided on six themes for working groups (WGs) and drafted a list of research questions. Senior WG members, mostly colorectal surgeons within the ESCP, were invited based on publication records and geographical aspects. Other specialties were included in the WGs where relevant. In addition, one trainee or PhD fellow was invited in each WG. All six WGs revised the research questions if necessary, did a literature search, created evidence tables where feasible, and drafted supporting text to each research question and statement. The text and statement proposals from each WG were arranged as one document by the first and last authors before online voting by all authors in two rounds. For the second voting ESCP national representatives were also invited. More than 90% agreement was considered a consensus. The final phrasing of the statements with < 90% agreement was discussed in a consensus meeting at the ESCP annual meeting in Vienna in September 2019. Thereafter, the first and the last author drafted the final text of the guideline and circulated it for final approval and for a third and final online voting of rephrased statements. RESULTS: This guideline contains 38 evidence based consensus statements on the management of diverticular disease. CONCLUSION: This international, multidisciplinary guideline provides an up to date summary of the current knowledge of the management of diverticular disease as a guidance for clinicians and patients.
Authors: Giuseppe Giuliani; Francesco Guerra; Diego Coletta; Antonio Giuliani; Lucia Salvischiani; Angela Tribuzi; Giuseppe Caravaglios; Alfredo Genovese; Andrea Coratti Journal: Int J Colorectal Dis Date: 2021-10-01 Impact factor: 2.571
Authors: Marcello Covino; Valerio Papa; Antonio Tursi; Benedetta Simeoni; Loris Riccardo Lopetuso; Lorenzo Maria Vetrone; Francesco Franceschi; Gianludovico Rapaccini; Antonio Gasbarrini; Alfredo Papa Journal: J Pers Med Date: 2021-01-29
Authors: R Nascimbeni; A Amato; R Cirocchi; A Serventi; A Laghi; M Bellini; G Tellan; M Zago; C Scarpignato; G A Binda Journal: Tech Coloproctol Date: 2020-11-05 Impact factor: 3.781